Publications

5808 Results

Validity of Adjuvant! Online in older patients with stage III colon cancer based on 2967 patients from the ACCENT database

Authors
D Papamichael;LA Renfro;C Matthaiou;G Yothers;L Saltz;KA Guthrie;E Van Cutsem;H Schmoll;R Labianca;T Andre;M O'Connell;SR Alberts;DG Haller;P Kountourakis;D Sargent
Journal / Conference
Journal of Geriatric Oncology 2016 Jul 25. pii: S1879-4068(16)30088-1. doi: 10.1016/j.jgo.2016.07.002 Jul 25 [Epub ahead of print]
Year
2016
Research Committee(s)
Gastrointestinal
PMID
PMID27468630
PMC
PMC5159186
Study Number(s)
SWOG-9415 (INT-0153) (CALGB-9498) (ECOG-S9415) (NCCTG-S9415)

Extending aromatase-inhibitor adjuvant therapy to 10 years

Authors
PE Goss;JN Ingle;KI Pritchard;NJ Robert;H Muss;J Gralow;K Gelmon;T Whelan;K Strasser Weippl;S Rubin;K Sturtz;AC Wolff;E Winer;C Hudis;A Stopeck;JT Beck;J Kaur;K Whelan;D Tu;WR Parulekar
Journal / Conference
New England Journal of Medicine Jul 21;375(3):209-219
Year
2016
Research Committee(s)
Breast
PMID
PMID27264120
PMC
PMC5024713
Study Number(s)
JMA17

A phase II randomized trial comparing standard and low dose rituximab combined with alemtuzumab as initial treatment of progressive chronic lymphocytic leukemia in older patients: a trial of the ECOG-ACRIN cancer research group (E1908)

Authors
C Zent;X Zang;RP Ketterling;C Hanson;E Libby;J Barrientos;T Call;J Call;JE Chang;JJ Liu;A Calvo;H Lazarus;J Rowe;S Luger;M Litzow;M Tallman
Journal / Conference
American Journal of Hematology Mar;91(3):308-312
Year
2016
Research Committee(s)
Leukemia
PMID
PMID26662208
PMC
PMC4806550
Study Number(s)
CTSU/E1908

Usage of Oregon’s Death with Dignity Act (DWDA)

Authors
C Blanke;M Leblanc;D Hershman;L Ellis;F Meyskens
Journal / Conference
Journal of Clinical Oncology 34, 2016 (suppl 26S; abstr 44); ASCO Palliative Care in Oncology Symposium (Sept 9-10, 2016, San Francisco, CA), poster
Year
2016
Research Committee(s)
Cancer Care Delivery

Continued excellent outcomes in previously untreated follicular lymphoma patients after treatment with CHOP plus rituximab or CHOP plus (131) iodine-tositumomab - long term follow-up of phase III randomized study SWOG S0016

Authors
M Shadman;H Li;L Rimsza;JP Leonard;M Kaminski;R Braziel;C Spier;A Gopal;D Maloney;B Cheson;S Dakhil;M Leblanc;SM Smith;RI Fisher;JW Friedberg;O Press
Journal / Conference
Blood 128:616;American Society of Hematology Annual Meeting (December 3-6, 2016, San Diego, CA), oral
Year
2016
Research Committee(s)
Lymphoma
Study Number(s)
S0016

ATRA, arsenic trioxide (ATO), and gemtuzumab ozogamicin (GO) is safe and highly effective in patients with previously untreated high-risk acute promyelocytic leukemia (APL): final results of the SWOG/Alliance/ECOG S0535 trial

Authors
JE Lancet;A Moseley;R Komrokji;S Coutre;D DeAngelo;M Tallman;M Litzow;M Othus;F Appelbaum
Journal / Conference
Blood 128:896; American Society of Hematology Annual Meeting(December 3-6, 2016, San Diego, CA), oral
Year
2016
Research Committee(s)
Leukemia
Study Number(s)
S0535

Sequential RCHOP, radioimmunotherapy and rituximab maintenance improves early outcomes in advanced stage follicular lymphoma: 5 year outcomes from SWOG 0801 [http://www.bloodjournal.org/content/128/22/614]

Authors
P Barr;H Li;WR Burack;M Leblanc;S Smith;AK Gopal;JD Floyd;D Persky;O Press;RI Fisher;JW Friedberg
Journal / Conference
Blood 128:614; American Society of Hematology Annual Meeting (December 3-6, 2016, San Diego, CA), oral presentation
Year
2016
Research Committee(s)
Lymphoma
Study Number(s)
S0801

Randomized, placebo controlled trial of duloxetine for aromatase inhibitor (AI)associated musculoskeletal symptoms (AIMSS) in early stage breast cancer (SWOG 1202)

Authors
NL Henry;J Unger;A Schott;L Fehrenbacher;P Flynn;D Prow;C Sharer;D Lew;A Moseley;M Fisch;C Moinpour;J Wade
Journal / Conference
San Antonio Breast Cancer Symposium (December 6-10, 2016, San Antonio, TX), oral
Year
2016
Research Committee(s)
Symptom Management and Survivorship
Study Number(s)
S1202

Rare cancer research in the National Clinical Trials Network:The SWOG Experience

Authors
A Schott
Journal / Conference
European Society for Medical Oncology (October 7-11, 2016, Copenhagen, Denmark), invited oral presentation
Year
2016
Research Committee(s)
Early Therapeutics and Rare Cancers
Study Number(s)
S1609

Recommendations for clinical trial development in follicular lymphoma

Authors
K Maddocks;P Barr;B Cheson;RF Little;L Baizer;B Kahl;JP Leonard;N Fowler;LI Gordon;B Link;JW Friedberg
Journal / Conference
Journal of the National Cancer Institute Dec 31;109(3)pii: djw255
Year
2016
Research Committee(s)
Lymphoma
PMID
PMID28040699
PMC
n/a - Review
Study Number(s)
S0016